The changes and role of TGF-β1/Smads signaling protein in the peritoneal fibrogenesis process in rats
Wenyuan Liu
Abstract
Wenyuan Liu
Abstract
Objective To explore the changes and role of TGF-β1/Smads signaling protein in peritoneal fibrogenesis process induced by 4.25% peritoneal dialysate and LPS in rats. Methods 32 male SD rats were randomly allocated into four groups:normal control group,normal rats (n=8); model group (n=24):rats were treated with daily intraperitoneal injection of 4.25% peritoneal dialysate (100ml/kg body weight) and LPS (0.6mg/kg,2 to 3 times per week); model group rats were randomly allocated into 2W model group,4W model group and 6W model group. A survival peritoneal equilibration test (PET) was performed in each animal,a tail blood sample and a peritoneal fluid sample were obtained at 0h and 4h. After 4h later,the animal was killed,the parietal peritoneum was stained with Masson and HE. The expression of α-SMA,TGF-β1,p-Smad2/3,and COL-Ⅰin visceral peritoneum was detected with confocal microscope by immunoflurence,Western-blot and RT-PCR. Results Normal peritoneum was covered by a layer flat mesothelial cell. Comparing with the rats in normal group,the peritoneum thickness and collagen deposition was significantly increased in the submesthelial compact zone and the expression of TGF-β1,p-Smad2/3,α-SMA,and Col-Ⅰwas upregulated in model group. Conclusions The activation of TGF-β/Smads signaling protein by 4.25% peritoneal dialysate and LPS involved in peritoneal fibrogenesis process ,the fibrosis model presents a persistent and slow progress in 6 weeks,thus it give us a basic model to investigate therapy for peritoneal fibrosis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the changes and role of TGF-β1/Smads signaling protein in peritoneal fibrogenesis process induced by 4.25% peritoneal dialysate and LPS in rats. Methods 32 male SD rats were randomly allocated into four groups:normal control group,normal rats (n=8); model group (n=24):rats were treated with daily intraperitoneal injection of 4.25% peritoneal dialysate (100ml/kg body weight) and LPS (0.6mg/kg,2 to 3 times per week); model group rats were randomly allocated into 2W model group,4W model group and 6W model group. A survival peritoneal equilibration test (PET) was performed in each animal,a tail blood sample and a peritoneal fluid sample were obtained at 0h and 4h. After 4h later,the animal was killed,the parietal peritoneum was stained with Masson and HE. The expression of α-SMA,TGF-β1,p-Smad2/3,and COL-Ⅰin visceral peritoneum was detected with confocal microscope by immunoflurence,Western-blot and RT-PCR. Results Normal peritoneum was covered by a layer flat mesothelial cell. Comparing with the rats in normal group,the peritoneum thickness and collagen deposition was significantly increased in the submesthelial compact zone and the expression of TGF-β1,p-Smad2/3,α-SMA,and Col-Ⅰwas upregulated in model group. Conclusions The activation of TGF-β/Smads signaling protein by 4.25% peritoneal dialysate and LPS involved in peritoneal fibrogenesis process ,the fibrosis model presents a persistent and slow progress in 6 weeks,thus it give us a basic model to investigate therapy for peritoneal fibrosis.
Key concepts: Peritoneum, Medicine, Western blot, Intraperitoneal injection, Internal medicine, Transforming growth factor, Animal model, Fibrosis